Rarity Bioscience superRCA technology assays
As part of a co-exclusive distribution agreement, Beckman Coulter Life Sciences will market and distribute Rarity Bioscience’s superRCA technology assays. The assays are claimed to accelerate the detection of mutations by using flow cytometry with logarithmically higher sensitivity compared to the current gold standard digital PCR (dPCR) method.
While traditional flow cytometry research analyses phenotypes, the platform combines a molecular assay based on rolling circle amplification and padlock probes with a flow cytometry readout for high sensitivity and specific multiplex detection of sequence variants, including single point DNA mutations. The assay offers high throughput, resulting in fast turnaround without the need for additional hardware, lowering the barriers to molecular research assays.
Phone: 1800 060 878
Waters BD FACSDiscover A7 Cell Analyzer
The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...
Lumiprobe CytoTracer fluorescent cell dyes
The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
